Volume: 41 Issue: 4
Year: 2021, Page: 859-861, Doi: https://doi.org/10.51248/.v41i4.843
A recurrent mass in the nose can pose diagnostic and therapeutic challenges. Even more so, if it exhibits rapid growth, displays unusual clinical features, is a rare histopathological diagnosis or if the patient is unavailable for regular follow-up. We present a case of a middle-aged retrovirus-positive man who underwent surgical removal of a recurrent nasal mass. Histopathology revealed a diagnosis of low-grade fibromyxoid sarcoma, a rare entity in the sinonasal tract. Immunohistochemistry plays a crucial role in clinching the diagnosis, especially for lesions with fibrous and myxoid components. Early and complete surgical resection diminishes the likelihood of recurrence and metastasis.
Keywords: Maxilla; immunohistochemistry; nasal neoplasms; sarcoma; sinonasal tract.
Deviprasad Dosemane, Cheryl Sarah Philipose, Deepa Adiga, Meera Niranjan Khadilkar, Sanchit Bajpai. Fibromyxoid sarcoma of maxilla. Biomedicine: 2021; 41(4): 859-861